Search Results

There are 959 results for: content related to: Pharmacokinetics of the combination raltegravir/atazanavir in HIV -1-infected patients

  1. Clinical Pharmacology Profile of Raltegravir, an HIV-1 Integrase Strand Transfer Inhibitor

    The Journal of Clinical Pharmacology

    Volume 51, Issue 10, October 2011, Pages: 1376–1402, Diana M. Brainard, Larissa A. Wenning, Julie A. Stone, John A. Wagner and Marian Iwamoto

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270010387428

  2. Effect of faldaprevir on raltegravir pharmacokinetics in healthy volunteers

    The Journal of Clinical Pharmacology

    Volume 55, Issue 4, April 2015, Pages: 384–391, David Joseph, Peter Rose, Natalja Strelkowa, Armin Schultz, Jeanette Garcia, Mabrouk Elgadi and Fenglei Huang

    Version of Record online : 8 DEC 2014, DOI: 10.1002/jcph.418

  3. Lack of a Clinically Meaningful Pharmacokinetic Effect of Rifabutin on Raltegravir: In Vitro/In Vivo Correlation

    The Journal of Clinical Pharmacology

    Volume 51, Issue 6, June 2011, Pages: 943–950, Dr Diana M. Brainard, Dr Kelem Kassahun, Dr Larissa A. Wenning, Ms Amelia S. Petry, Ms Chengcheng Liu, Dr Jared Lunceford, Dr Niresh Hariparsad, Mr Roy Eisenhandler, Ms Alisha Norcross, Dr Emanuel P. DeNoia, Dr Julie A. Stone, Dr John A. Wagner and Dr Marian Iwamoto

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010375959

  4. The Effect of Raltegravir on the Glucuronidation of Lamotrigine

    The Journal of Clinical Pharmacology

    Volume 49, Issue 10, October 2009, Pages: 1220–1227, Dr Matthijs van Luin, Ms Angela Colbers, Dr Corrien P. W. G. M. Verwey-van Wissen, Dr Eleonora W. J. van Ewijk-Beneken-Kolmer, Dr Mike van der Kolk, Dr Arjen Hoitsma, Dr Hugo Gomes da Silva and Dr David M. Burger

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009345689

  5. Atazanavir increases the plasma concentrations of 1200 mg raltegravir dose

    Biopharmaceutics & Drug Disposition

    Volume 37, Issue 9, December 2016, Pages: 533–541, Rajesh Krishna, Lilly East, Patrick Larson, Chandni Valiathan, Kathleen Deschamps, Julie Ann Luk, Crystal Bethel-Brown, Helen Manthos, John Brejda and Michael Gartner

    Version of Record online : 4 NOV 2016, DOI: 10.1002/bdd.2043

  6. You have free access to this content
    Intracellular and plasma steady-state pharmacokinetics of raltegravir, darunavir, etravirine and ritonavir in heavily pre-treated HIV-infected patients

    British Journal of Clinical Pharmacology

    Volume 69, Issue 5, May 2010, Pages: 475–483, Rob Ter Heine, Jan Willem Mulder, Eric C. M. Van Gorp, Jiri F. P. Wagenaar, Jos H. Beijnen and Alwin D. R. Huitema

    Version of Record online : 1 FEB 2010, DOI: 10.1111/j.1365-2125.2010.03634.x

  7. Raltegravir Thorough QT/QTc Study: A Single Supratherapeutic Dose of Raltegravir Does Not Prolong the QTcF Interval

    The Journal of Clinical Pharmacology

    Volume 48, Issue 6, June 2008, Pages: 726–733, Dr M. Iwamoto, Dr J. T. Kost, Dr G. C. Misty, Dr L. A. Wenning, S. A. Breidinger, Dr T. C. Marbury, Dr J. A. Stone, Dr K. M. Gottesdiener, Dr D. M. Bloomfield and Dr J. A. Wagner

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008318007

  8. Lack of a Pharmacokinetic Effect of Raltegravir on Midazolam: In Vitro/In Vivo Correlation

    The Journal of Clinical Pharmacology

    Volume 48, Issue 2, February 2008, Pages: 209–214, Dr Marian Iwamoto, Dr Kelem Kassahun, Dr Matthew D. Troyer, Dr William D. Hanley, Ms Ping Lu, Ms Alisha Rhoton, Ms Amelia S. Petry, Dr Kalyan Ghosh, Mr Eric Mangin, Dr Emanuel P. DeNoia, Dr Larissa A. Wenning, Dr Julie A. Stone, Dr Keith M. Gottesdiener and Dr John A. Wagner

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007310382

  9. Effect of Raltegravir on the Pharmacokinetics of Methadone

    The Journal of Clinical Pharmacology

    Volume 50, Issue 12, December 2010, Pages: 1461–1466, Dr Matt S. Anderson, Ms Julie Ann Mabalot Luk, Dr William D. Hanley, Dr Bo Jin, Dr Robert A. Riesenberg, Dr Larissa A. Wenning, Dr Jeffery A. Chodakewitz, Dr John A. Wagner and Dr Marian Iwamoto

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009360981

  10. Efavirenz does not meaningfully affect the single dose pharmacokinetics of 1200 mg raltegravir

    Biopharmaceutics & Drug Disposition

    Volume 37, Issue 9, December 2016, Pages: 542–549, Rajesh Krishna, Lilly East, Patrick Larson, Tara Siringhaus, Lisa Herpok, Crystal Bethel-Brown, Helen Manthos, John Brejda and Michael Gartner

    Version of Record online : 14 NOV 2016, DOI: 10.1002/bdd.2045

  11. Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir

    Journal of Pharmacy and Pharmacology

    Volume 68, Issue 11, November 2016, Pages: 1359–1365, Rajesh Krishna, Lilly East, Patrick Larson, Chandni Valiathan, Kristin Butterfield, Yang Teng and Martha Hernandez-Illas

    Version of Record online : 27 SEP 2016, DOI: 10.1111/jphp.12632

  12. Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimens

    Journal of Medical Virology

    Volume 82, Issue 1, January 2010, Pages: 116–122, Fausto Baldanti, Stefania Paolucci, Roberto Gulminetti, Micaela Brandolini, Giorgio Barbarini and Renato Maserati

    Version of Record online : 30 NOV 2009, DOI: 10.1002/jmv.21651

  13. Impaired Maraviroc and Raltegravir Clearance in a Human Immunodeficiency Virus–Infected Patient with End-Stage Liver Disease and Renal Impairment: A Management Dilemma

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 1, January 2012, Pages: e1–e6, Alice K. Pau, Scott R. Penzak, Sarita D. Boyd, Mary McLaughlin and Caryn G. Morse

    Version of Record online : 4 JAN 2012, DOI: 10.1002/PHAR.1003

  14. You have free access to this content
    Poster Exhibition Abstracts

    HIV Medicine

    Volume 10, Issue s2, October 2009, Pages: 45–221,

    Version of Record online : 19 OCT 2009, DOI: 10.1111/j.1468-1293.2009.00792.x

  15. You have free access to this content
    Assessment of the pharmacokinetics of co-administered maraviroc and raltegravir

    British Journal of Clinical Pharmacology

    Volume 69, Issue 1, January 2010, Pages: 51–57, Emma Andrews, Paul Glue, Juanzhi Fang, Penelope Crownover, Randall Tressler and Bharat Damle

    Version of Record online : 22 SEP 2009, DOI: 10.1111/j.1365-2125.2009.03546.x

  16. Integrase Inhibitors: A New Treatment Option for Patients with Human Immunodeficiency Virus Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 1, January 2008, Pages: 90–101, Dr. Todd Correll and Dr. Olga M. Klibanov

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.1.90

  17. Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV-infected children 4 weeks to 18 years of age

    The Journal of Clinical Pharmacology

    Volume 55, Issue 7, July 2015, Pages: 748–756, Matthew L. Rizk, Lihong Du, Chantelle Bennetto-Hood, Larissa Wenning, Hedy Teppler, Brenda Homony, Bobbie Graham, Carrie Fry, Sharon Nachman, Andrew Wiznia, Carol Worrell, Betsy Smith and Edward P. Acosta

    Version of Record online : 13 APR 2015, DOI: 10.1002/jcph.493

  18. Acceptable Plasma Concentrations of Raltegravir and Etravirine When Administered by Gastrostomy Tube in a Patient with Advanced Multidrug-Resistant Human Immunodeficiency Virus Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 2, February 2012, Pages: 142–147, Uriel Sandkovsky, Susan Swindells, Ryan Moore, Edward P. Acosta and Courtney V. Fletcher

    Version of Record online : 30 JAN 2012, DOI: 10.1002/PHAR.1015

  19. Simultaneous determination of raltegravir and raltegravir glucuronide in human plasma by liquid chromatography–tandem mass spectrometric method

    Journal of Mass Spectrometry

    Volume 46, Issue 2, February 2011, Pages: 202–208, Ling-Zhi Wang, Lawrence Soon-U Lee, Win-Lwin Thuya, Gaik Hong Soon, Li-Ren Kong, Pei-Ling Nye, Edmund Jon Deoon Lee, Charles Flexner and Boon-Cher Goh

    Version of Record online : 24 JAN 2011, DOI: 10.1002/jms.1874

  20. Effect of Low-, Moderate-, and High-Fat Meals on Raltegravir Pharmacokinetics

    The Journal of Clinical Pharmacology

    Volume 51, Issue 3, March 2011, Pages: 422–427, Dr Diana M. Brainard, Mr Evan J. Friedman, Dr Bo Jin, Dr Sheila A. Breidinger, Dr Maria D. Tillan, Dr Larissa A. Wenning, Dr Julie A. Stone, Dr Jeffrey A. Chodakewitz, Dr John A. Wagner and Dr Marian Iwamoto

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010367652